Cargando…
MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target
Women worldwide are more likely to develop breast cancer (BC) than any other type of cancer. The treatment of BC depends on the subtype and stage of the cancer, such as surgery, radiotherapy, chemotherapy, and immunotherapy. Although significant progress has been made in recent years, advanced or me...
Autores principales: | Liu, Haoyu, Wang, Zhicheng, Zhou, Yuntao, Yang, Yanming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350567/ https://www.ncbi.nlm.nih.gov/pubmed/37465670 http://dx.doi.org/10.3389/fimmu.2023.1199273 |
Ejemplares similares
-
Immunotherapy of targeting MDSCs in tumor microenvironment
por: Sui, Hongshu, et al.
Publicado: (2022) -
Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
por: Gao, Xidan, et al.
Publicado: (2021) -
MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation
por: Wang, Yungang, et al.
Publicado: (2019) -
Evolution of Our Understanding of Myeloid Regulatory Cells: From MDSCs to Mregs
por: Manjili, Masoud H., et al.
Publicado: (2014) -
Mesenchymal Stem Cell Enhances the Function of MDSCs in Experimental Sjögren Syndrome
por: Tian, Jie, et al.
Publicado: (2020)